These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 1825618)
1. Effects of streptozotocin/bis-chloroethylnitrosourea combination therapy on O6-methylguanine DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro. Pieper RO; Futscher BW; Dong Q; Erickson LC Cancer Res; 1991 Mar; 51(6):1581-5. PubMed ID: 1825618 [TBL] [Abstract][Full Text] [Related]
2. Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro. Marathi UK; Kroes RA; Dolan ME; Erickson LC Cancer Res; 1993 Sep; 53(18):4281-6. PubMed ID: 8364924 [TBL] [Abstract][Full Text] [Related]
3. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity. Marathi UK; Dolan ME; Erickson LC Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784 [TBL] [Abstract][Full Text] [Related]
4. Comparisons between sensitive and resistant human tumor cell lines regarding effects of polyamine depletion on chloroethylnitrosourea efficacy. Seidenfeld J; Sprague WS Cancer Res; 1990 Feb; 50(3):521-6. PubMed ID: 2137022 [TBL] [Abstract][Full Text] [Related]
5. [Effect of pretreatment with N-methyl-N-nitrosourea or streptozotocin on the cytotoxicity and the induction of sister chromatid exchanges in human and rodent brain tumor cells treated with chloroethylnitrosourea]. Tokuda K Hokkaido Igaku Zasshi; 1992 Jul; 67(4):462-74. PubMed ID: 1427592 [TBL] [Abstract][Full Text] [Related]
6. Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo. Marathi UK; Dolan ME; Erickson LC Biochem Pharmacol; 1994 Nov; 48(11):2127-34. PubMed ID: 7802703 [TBL] [Abstract][Full Text] [Related]
7. O6-methylguanine-DNA methyltransferase activity and sensitivity of human tumor cell lines to bis-chloroethylnitrosourea. Chen J; Zhang Y; Sui J; Chen Y Chin Med Sci J; 1992 Dec; 7(4):187-90. PubMed ID: 1339155 [TBL] [Abstract][Full Text] [Related]
8. Collateral sensitivity to nitrosoureas in multidrug-resistant cells selected with verapamil. Futscher BW; Campbell K; Dalton WS Cancer Res; 1992 Sep; 52(18):5013-7. PubMed ID: 1387586 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells. Ma LC; Kuo CC; Liu JF; Chen LT; Chang JY Mol Pharmacol; 2008 Aug; 74(2):517-26. PubMed ID: 18492797 [TBL] [Abstract][Full Text] [Related]
10. Modulation of 1,3-bis-(2-chloroethyl)-1-nitrosourea resistance in human tumor cells using hammerhead ribozymes designed to degrade O6-methylguanine DNA methyltransferase mRNA. Zhang Q; Ohannesian DW; Kreklau EL; Erickson LC J Pharmacol Exp Ther; 2001 Jul; 298(1):141-7. PubMed ID: 11408535 [TBL] [Abstract][Full Text] [Related]
11. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761 [TBL] [Abstract][Full Text] [Related]
12. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU. Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853 [TBL] [Abstract][Full Text] [Related]
13. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA. Maze R; Kapur R; Kelley MR; Hansen WK; Oh SY; Williams DA J Immunol; 1997 Jan; 158(2):1006-13. PubMed ID: 8993023 [TBL] [Abstract][Full Text] [Related]
14. Hammerhead ribozyme-mediated sensitization of human tumor cells after treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. Zhang Q; Ohannesian DW; Erickson LC J Pharmacol Exp Ther; 2004 May; 309(2):506-14. PubMed ID: 14742745 [TBL] [Abstract][Full Text] [Related]
15. Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial. Panella TJ; Smith DC; Schold SC; Rogers MP; Winer EP; Fine RL; Crawford J; Herndon JE; Trump DL Cancer Res; 1992 May; 52(9):2456-9. PubMed ID: 1533174 [TBL] [Abstract][Full Text] [Related]
16. Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice. Allay JA; Davis BM; Gerson SL Exp Hematol; 1997 Sep; 25(10):1069-76. PubMed ID: 9293904 [TBL] [Abstract][Full Text] [Related]
17. Both extraneuronal monoamine transporter and O(6)-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl-3-sarcosinamide- 1-nitrosourea in human tumor xenografts. Chen ZP; Wang ZM; Carter CA; Alley MC; Mohr G; Panasci LC J Pharmacol Exp Ther; 2001 Mar; 296(3):712-5. PubMed ID: 11181897 [TBL] [Abstract][Full Text] [Related]
18. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells. Seidenfeld J; Barnes D; Block AL; Erickson LC Cancer Res; 1987 Sep; 47(17):4538-43. PubMed ID: 3113720 [TBL] [Abstract][Full Text] [Related]
19. Depletion of O6-methylguanine-DNA methyltransferase and potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea antitumor activity by O6-benzylguanine in vitro. Chen JM; Zhang YP; Moschel RC; Ikenaga M Carcinogenesis; 1993 May; 14(5):1057-60. PubMed ID: 8504466 [TBL] [Abstract][Full Text] [Related]
20. Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea. Kokkinakis DM; Moschel RC; Pegg AE; Schold SC Clin Cancer Res; 1999 Nov; 5(11):3676-81. PubMed ID: 10589786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]